Antivenom Choice in the Management of Snake Envenomation
- PMID: 40996627
- PMCID: PMC12511495
- DOI: 10.1007/s13181-025-01100-w
Antivenom Choice in the Management of Snake Envenomation
Keywords: Antivenom; Control; Envenomation; Outcomes; Snakebite.
References
-
- CroFab. [crotalidae polyvalent immune fab (ovine)] prescribing information. West Conshohocken, PA: BTG International, Inc.; January 2018.
-
- ANAVIP [crotalidae. Immune F(ab’)2 (equine)] prescribing information. Franklin, TN. April: Rare Disease Therapeutics, Inc.; 2021.
-
- Spyres MB, Padilla GK, Gerkin RD, et al. Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab’)2 (equine) antivenom and crotalidae immune polyvalent fab (ovine) antivenom reported to the North American snakebite sub-registry. Clin Toxicol (Phila). 2022;60(7):838–42. 10.1080/15563650.2022.2042550. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
